Here’s our fortnightly wrap of all the news driving ASX health stocks.

Of the ASX’s 134-odd small cap health stocks and of those which were trading on Wednesday, 71 were in positive territory over the last fortnight, 11 were flat and 52 saw their share prices fall.

Code Name Price $ (June 10) 2 week return % 1 year return % Market cap
CTE CRYOSITE LTD 0.185 118 340 $8,669,019
ESE ESENSE-LAB LTD-CDI 0.017 80 -10 $3,421,385
DXB DIMERIX LTD 0.44 59 444 $78,056,488
SOM SOMNOMED LTD 1.5 49 5 $124,516,056
ACW ACTINOGEN MEDICAL LTD 0.026 39 150 $27,905,784
NTI NEUROTECH INTERNATIONAL LTD 0.008 33 -65 $1,721,725
ZLD ZELIRA THERAPEUTICS LTD 0.063 31 54 $61,269,288
PTX PRESCIENT THERAPEUTICS LTD 0.064 31 56 $25,232,680
ACR ACRUX LTD 0.17 30 -10 $29,494,240
OVN OVENTUS MEDICAL LTD 0.34 29 53 $53,086,748
AVE AVECHO BIOTECHNOLOGY LTD 0.009 29 200 $14,377,117
1ST 1ST GROUP LTD 0.035 28 -20 $15,710,825
SCU STEMCELL UNITED LTD 0.014 27 -18 $8,982,517
PIQ PROTEOMICS INTERNATIONAL LAB 0.515 26 48 $42,265,204
SDX SIENNA CANCER DIAGNOSTICS LT 0.076 26 39 $30,820,362
GLH GLOBAL HEALTH LTD 0.175 25 44 $7,367,206
OSL ONCOSIL MEDICAL LTD 0.13 24 121 $108,173,120
BNO BIONOMICS LTD 0.071 23 -16 $36,493,952
ZNO ZOONO GROUP LTD 2.28 22 1982 $374,673,088
OPT OPTHEA LTD 3.49 20 394 $904,370,112
ALC ALCIDION GROUP LTD 0.18 20 44 $178,324,928
PAA PHARMAUST LTD 0.115 20 211 $34,732,420
PAR PARADIGM BIOPHARMACEUTICALS 3.25 20 121 $710,169,472
RSH RESPIRI LTD 0.084 18 -38 $54,097,472
RNO RHINOMED LTD 0.084 18 -60 $14,467,114
SVA SIMAVITA LTD-CDI 0.023 15 35 $12,966,897
BD1 BARD1 LIFE SCIENCES LTD 0.03 15 36 $42,382,736
PSQ PACIFIC SMILES GROUP LTD 1.6 14 35 $245,624,880
IBX IMAGION BIOSYSTEMS LTD 0.032 14 49 $24,370,564
GSS GENETIC SIGNATURES LTD 2.24 14 105 $319,448,640
NC6 NANOLLOSE LTD 0.04 14 -28 $4,230,000
M7T MACH7 TECHNOLOGIES LTD 0.79 14 119 $144,577,216
JHL JAYEX HEALTHCARE LTD 0.025 14 -49 $4,409,076
ICS ICSGLOBAL LTD 2.05 14 115 $21,738,238
CDX CARDIEX LTD 0.025 13 -19 $19,583,442
IMU IMUGENE LTD 0.036 13 140 $159,334,944
SUD SUDA PHARMACEUTICALS LTD 0.042 11 -71 $5,974,685
VBS VECTUS BIOSYSTEMS LTD 0.72 10 106 $17,031,468
IMM IMMUTEP LTD 0.175 9 -32 $85,335,416
AMT ALLEGRA ORTHOPAEDICS LTD 0.12 9 20 $11,947,086
ANR ANATARA LIFESCIENCES LTD 0.19 9 -42 $9,472,674
BXN BIOXYNE LTD 0.013 8 -28 $8,321,890
AHX APIAM ANIMAL HEALTH LTD 0.47 8 16 $56,549,612
PAB PATRYS LTD 0.015 8 -46 $15,016,265
OCC ORTHOCELL LTD 0.355 8 -12 $65,568,048
THC THC GLOBAL GROUP LTD 0.395 7 -7 $59,141,536
MVF MONASH IVF GROUP LTD 0.595 6 -49 $233,780,896
VLS VITA LIFE SCIENCES LTD 0.57 6 -16 $30,827,088
CYC CYCLOPHARM LTD 1.495 5 3 $118,492,136
ELX ELLEX MEDICAL LASERS LTD 0.52 5 -6 $75,390,600
UCM USCOM LTD 0.235 5 45 $33,711,376
JHC JAPARA HEALTHCARE LTD 0.575 5 -50 $155,003,456
AZV AZURE HEALTHCARE LTD 0.07 4 -10 $19,893,226
AVH AVITA MEDICAL LTD 0.4825 4 43 $1,039,714,432
ONE ONEVIEW HEALTHCARE PLC-CDI 0.048 4 -80 $8,487,363
LBT LBT INNOVATIONS LTD 0.165 3 14 $38,864,064
NYR NYRADA INC-CDI 0.17 3 -15 $18,595,232
RAP RESAPP HEALTH LTD 0.17 3 3 $128,645,912
NSB NEUROSCIENTIFIC BIOPHARMACEU 0.19 3 29 $14,109,225
ONT 1300 SMILES LTD 5.45 3 -12 $129,047,192
MDR MEDADVISOR LTD 0.615 3 56 $150,479,120
HLA HEALTHIA LTD 1.055 2 23 $66,501,560
OIL OPTISCAN IMAGING LTD 0.044 2 -6 $21,022,268
PYC PYC THERAPEUTICS LTD 0.09 2 246 $263,828,512
RHY RHYTHM BIOSCIENCES LTD 0.095 2 -42 $9,571,250
S66 STAR COMBO PHARMA LTD 0.485 2 -26 $65,095,968
BWX BWX LTD 3.88 2 131 $480,847,072
CGS COGSTATE LTD 0.32 2 56 $55,297,180
AT1 ATOMO DIAGNOSTICS LTD 0.32 2 60 $185,155,680
CP1 CANNPAL ANIMAL THERAPEUTICS 0.092 1 -39 $8,846,875
RCE RECCE PHARMACEUTICALS LTD 0.715 1 264 $104,094,920
TLX TELIX PHARMACEUTICALS LTD 1.425 0 35 $359,048,672
IVX INVION LTD 0.008 0 -47 $44,004,852
MEB MEDIBIO LTD 0.007 0 -40 $6,068,780
AC8 AUSCANN GROUP HOLDINGS LTD 0.17 0 -53 $53,898,052
CMP COMPUMEDICS LTD 0.49 0 -2 $87,695,656
LCT LIVING CELL TECHNOLOGIES LTD 0.013 0 -58 $7,428,733
NEU NEUREN PHARMACEUTICALS LTD 1.63 0 42 $173,325,632
LSH LIFESPOT HEALTH LTD 0.03 0 -58 $2,630,920
VTI VISIONEERING TECH-CDI 0.017 0 -64 $13,291,766
PAL PALLA PHARMA LTD 0.81 0 -26 $100,758,384
PNV POLYNOVO LTD 2.7 0 113 $1,778,326,784
CYP CYNATA THERAPEUTICS LTD 0.665 -1 -47 $77,738,168
OSX OSTEOPORE LTD 0.485 -1 143 $49,602,944
IMC IMMURON LTD 0.36 -1 -39 $14,709,128
KZA KAZIA THERAPEUTICS LTD 0.43 -1 4 $38,785,332
SDI SDI LTD 0.74 -2 -14 $87,960,496
CAJ CAPITOL HEALTH LTD 0.22 -2 2 $224,971,376
RHT RESONANCE HEALTH LTD 0.185 -3 68 $82,098,176
TD1 TALI DIGITAL LTD 0.03 -3 76 $22,479,156
MX1 MICRO-X LTD 0.14 -3 -43 $50,003,496
ATX AMPLIA THERAPEUTICS LTD 0.135 -4 23 $8,972,530
ADR ADHERIUM LTD 0.027 -4 17 $16,235,240
APH AUSTRALIAN PRIMARY HEMP LTD 0.125 -4 -43 $8,719,392
NXS NEXT SCIENCE LTD 1.495 -4 -53 $269,536,064
AGH ALTHEA GROUP HOLDINGS LTD 0.365 -4 -44 $86,324,704
MXC MGC PHARMACEUTICALS LTD 0.024 -4 -54 $37,814,696
ADO ANTEOTECH LTD 0.022 -4 73 $36,169,844
PBP PROBIOTEC LTD 1.86 -5 23 $139,088,704
MDC MEDLAB CLINICAL LTD 0.205 -5 -46 $47,810,472
RAC RACE ONCOLOGY LTD 0.305 -5 408 $35,255,700
1AD ADALTA LTD 0.1 -5 -48 $13,279,595
VHT VOLPARA HEALTH TECHNOLOGIES 1.37 -5 -25 $347,055,296
IHL IMPRESSION HEALTHCARE LTD 0.052 -5 121 $38,688,840
BIT BIOTRON LTD 0.088 -5 29 $61,770,080
PXS PHARMAXIS LTD 0.086 -5 -66 $33,991,432
RGS REGENEUS LTD 0.071 -7 -24 $19,725,574
UBI UNIVERSAL BIOSENSORS INC-CDI 0.21 -7 5 $37,266,468
MVP MEDICAL DEVELOPMENTS INTERNA 7.65 -7 47 $504,644,640
SKN SKIN ELEMENTS LTD 0.08 -7 82 $25,411,448
MMJ MMJ GROUP HOLDINGS LTD 0.125 -8 -51 $27,594,478
IDT IDT AUSTRALIA LTD 0.17 -8 0 $40,683,216
CAN CANN GROUP LTD 1.08 -9 -47 $158,249,440
BOT BOTANIX PHARMACEUTICALS LTD 0.047 -9 -52 $46,689,508
PGC PARAGON CARE LTD 0.15 -12 -65 $50,682,792
MEM MEMPHASYS LTD 0.058 -12 152 $43,730,484
FFC FARMAFORCE LTD 0.07 -13 -39 $9,013,969
OSP OSPREY MEDICAL INC-CDI 0.014 -13 -87 $17,997,570
IPD IMPEDIMED LTD 0.07 -13 -33 $74,125,600
FTT FACTOR THERAPEUTICS LTD 0.003 -14 -40 $3,128,507
GMV G MEDICAL INNOVATION HOLDING 0.06 -14 -74 $39,163,408
HCT HOLISTA COLLTECH LTD 0.145 -15 116 $39,925,616
ANP ANTISENSE THERAPEUTICS LTD 0.067 -15 31 $30,793,472
ICR INTELICARE HOLDINGS LTD 0.4 -18 100 $28,795,384
CDY CELLMID LTD 0.185 -18 -5 $22,329,762
NOX NOXOPHARM LTD 0.185 -18 -62 $31,523,232
BPH BPH ENERGY LTD 0.008 -20 -20 $2,985,795
ATH ALTERITY THERAPEUTICS LTD 0.016 -20 -53 $16,597,729
PCK PAINCHEK LTD 0.155 -22 -17 $150,150,752
EXL ELIXINOL GLOBAL LTD 0.225 -22 -93 $43,388,340
CPH CRESO PHARMA LTD 0.056 -25 -91 $14,236,152
GTG GENETIC TECHNOLOGIES LTD 0.005 -29 -23 $37,568,900
ALT ANALYTICA LTD 0.003 -33 -60 $7,039,225
DVL DORSAVI LTD 0.015 -35 -76 $3,471,413

 

A rising tide lifts the strangest of boats and, this week, not the ones with the biggest news.

Cryosite (ASX:CTE), a company that cold-stores biological samples, saw a share price surge over the last two weeks.

On June 28 there was a surge of buying, with over 700,000 shares acquired.

Since September chairman Andrew Kroger has been the only director, and only substantial shareholder trading in the stock. He now has a 40.31 per cent interest, as of the last notice in April.

Aside from that, there’s few other clues as to why this stock rose 118 per cent in the last fortnight.

Of the two most highly anticipated pieces of news, one delivered a disappointment and the other didn’t deliver at all — or at least, not the news investors expected.

The other piece of news was eye biotech Opthea (ASX:OPT), which disappointed investors with clinical trial results labelled by one analyst as “underwhelming”.

Its drug OPT-302 had been studied in a clinical trial as a treatment for diabetic macular edema (DME).

It met primary and secondary endpoints, but the results did not show a significant difference to the standard of care.

The stock, which has risen strongly over the last two weeks in anticipation of a repeat of a spectacular trial last year into wet-age related macular degeneration, dropped by 8 per cent in the hours after the news was announced.

Dimerix (ASX:DXB) shares surged not after it released data from the two clinical trials it’s running, but because its fibrosis drug has been chosen for a global study on COVID-19.

At one point the stock was up over 120 per cent.

Sleep apnoea company Somnomed (ASX:SOM) was having a — very cautious — celebration last week after sales slipped not nearly as badly following the COVID-19 closures.

Sales of its mouthguard, fitted by dentists, that helps combat snoring, tooth grinding, and sleep apnoea, were down 61 per cent.

Somnomed CEO Neil Verdal-Austin said they were “cautiously optimistic” as countries in Europe, North America and Asia re-open.

The timely $15.5m capital raising in March combined with pay cuts across the board and a knife taken to costs means the company is in a hopeful position.

And Neurotech International (ASX:NTI) was called out by the ASX for its rapid price rise.

It’s rare for a company to admit, but it did in fact know something the market didn’t — but clearly some people did, and traded on it.

“The company was aware of information concerning it that had not been announced to the market,” Neurotech revealed.

“The information related to negotiation of a proposed heads of agreement for a strategic collaboration in respect of rights under a distribution agreement to market and sell TGA approved IgM, IgG Antibody COVID-19 testing kits in Australia, New Zealand (exclusive) and all other countries (non-exclusive) other than China.”

Two months ago that would have sent the stock stratospheric. Today? A mere 33 per cent. And that was from a starting point of 0.8c when a couple of grand can move the market.